Trial site
The Third Affiliated Hospital of Xinxiang Medical University
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation2 trials
- Coronary artery disease2 trials
- Heart failure2 trials
- Hepatitis B2 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Liver and biliary tract cancer1 trial
- Macular degeneration1 trial
- Obesity1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Phase
- Phase 39 trials
- Status
- Completed5 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Bayer1 trial
- Beijing 302 Hospital1 trial
- Boehringer Ingelheim1 trial
- Daiichi Sankyo1 trial
- and 6 more
Running trials
Recruiting
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Not yet recruiting
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Hepatitis B2 recruiting
- Coronary artery disease1 recruiting
- Liver and biliary tract cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
A Study of IBI362 in Participants With Obesity or Overweight
Completed
A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD
Completed
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
Site data: ClinicalTrials.govUpdated 17 Nov 2026